The Additive Clinical Value of F-18-FDG PET/CT in Defining the Recurrence of Disease in Patients With Differentiated Thyroid Cancer Who Have Isolated Increased Antithyroglobulin Antibody Levels

---

Copy For Citation

ÖZKAN E., SOYDAL Ç., ARAZ M., Aras G., İBİŞ E.

CLINICAL NUCLEAR MEDICINE, vol.37, no.8, pp.755-758, 2012 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 37 Issue: 8
• Publication Date: 2012
• Doi Number: 10.1097/rlu.0b013e31825ae77b
• Journal Name: CLINICAL NUCLEAR MEDICINE
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.755-758
• Keywords: differentiated thyroid cancers, antithyroglobulin antibody, F-18-FDG PET/CT, SERUM THYROGLOBULIN MEASUREMENT, FOLLOW-UP, CARCINOMA, AUTOANTIBODIES, PREVALENCE, SCAN
• Ankara University Affiliated: Yes

Abstract

Aim: The aim of this study was to investigate the additive clinical value of F-18-FDG PET/CT in defining the recurrence of disease in patients with differentiated thyroid cancer (DTC) who have isolated increased antithyroglobulin antibody (TgAb) levels with undetectable thyroglobulin (Tg) levels and negative I-131 whole-body scintigraphy (wbs).